Crossmark

AI-based opportunistic CT screening of incidental cardiovascular disease, osteoporosis, and sarcopenia: cost-effectiveness analysis

Published Online: 2023-01-20

Authors

Pickhardt, Perry J. https://orcid.org/0000-0002-5534-8202
Correale, Loredana

Hassan, Cesare
Funding

Funding for this research was provided by:

Nanox-AI and Bracco
License Information

Text and Data Mining valid from 2023-01-20

Version of Record valid from 2023-01-20
More Information

Article History

Received: 31 October 2022

Revised: 2 January 2023

Accepted: 4 January 2023

First Online: 20 January 2023

Declarations

:

: Dr. Pickhardt is an advisor to Nanox, Bracco, and GE Healthcare; Dr. Hassan is a consultant for Fujifilm, Olympus, Norgine, and Cosmo.

Document is current